01 1Viatris
01 1PALIPERIDONE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-13
Pay. Date : 2018-06-18
DMF Number : 23367
Submission : 2009-12-14
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PALIPERIDONE USP, with a corresponding US DMF Number 23367.
Remarkably, this DMF maintains an Active status since its submission on December 14, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2018, and payment made on June 18, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
